Press releases

Stay informed about the latest developments and research results of the DZNE. We are available to answer press inquiries over here.

Symbol image
DZNE launches the research area “systems medicine”
The DZNE is expanding its research activities to include the area of “systems medicine”. The focus is on the network of relationships between the mechanisms of brain diseases.
Symbolic image, not for editorial use.
Lumpy proteins stiffen blood vessels of the brain
Study puts spotlight on a new risk factor for vascular dementia.
Symbolic image, not for editorial use
“Hotspots” of a corona infection in the human body
Researchers identify new possible entry points for SARS-CoV-2 into human bodies.
Illustration of the function of CPTX.
A tailor-made molecule that ties nerve connections
Synthetic compound could serve as prototype for a novel class of drugs to treat neurological damage.
Symbol image shows yellow brain on blue background
Disorders in movement
A European research alliance headed by the DZNE tracks the onset of ataxias.
Symbol image shows magnifying glass over Coronavirus signature
COVID-19: Immune system derails
Researchers publish current coronavirus findings in "Cell"
Symbolic image of a brain
A “feeling” for dementia?
A research team led by the DZNE concludes that personal perception can be an important indicator for the early detection of Alzheimer’s disease. Early diagnosis and therapy development could benefit from these findings.
Virtual cohorts for medical research
Researchers at the DZNE and the Helmholtz Center for Information Security intend to use “artificial intelligence” to facilitate the transfer of genomic data for research purposes under the strict constraints of data protection.
Symbolic image of a brain
DZNE welcomes Federal Government’s National Dementia Strategy
The DZNE is part of alliance for a dementia-friendly Germany.
Symbolic image of a compass
Noise disturbs the brain’s compass
In “Nature Communications”, DZNE scientists report on causes for troubles in spatial navigation and ties to the research on Alzheimer’s disease.